Unlocked Labs is a technology company.
Unlocked Labs has raised $600K across 2 funding rounds.
Unlocked Labs has raised $600K in total across 2 funding rounds.
Unlocked Labs has raised $600K in total across 2 funding rounds.
Unlocked Labs's investors include KRM Interests LLC, Oak HC/FT, Oyster Ventures, Pareto Holdings, Seaside Ventures, Social Capital, Astanor Ventures, SOSV, Mayfield, True Ventures.
Unlocked Labs Inc. is a biotech startup founded in 2021 in Laramie, Wyoming, developing precision single-strain probiotics that activate dormant enzymes for consistent toxin removal, targeting waste products in the body rather than broad microbial community effects.[1] It serves consumers in health, wellness, and medical sectors by addressing limitations in traditional large-dose, multi-strain probiotics lacking specific mechanisms, with funding from investors like the State of Wyoming, Astanor Ventures, SOSV, NIH, and NSF SBIR/STTR.[1] Note: Distinct from UnlockEd Labs (unlockedlabs.org), a nonprofit building secure edtech tools for justice-impacted individuals and correctional systems to enhance education access and system transformation.[2][5][6]
The company shows early growth momentum through participation in IndieBio SF Demo Day and grants from prestigious sources, positioning it in the precision biotech space amid rising demand for targeted health solutions.[1]
Unlocked Labs Inc. was founded in 2021 by James Francis, COO with an M.S. in Electrical Engineering from the University of Wyoming and a background as an outcomes-driven entrepreneur skilled in executing detailed roadmaps.[1] The idea emerged from recognizing flaws in the existing probiotic market—large-dose, multi-strain products without clear mechanisms—and pivoting to biology-driven tools that activate specific bacterial enzymes for reliable waste removal, leveraging genetic engineering for precision.[1] Early traction includes raising funds from state and federal sources plus VCs like SOSV, and showcasing at accelerators like IndieBio.[1]
Unlocked Labs rides the wave of precision biotech and personalized health, where targeted microbiome interventions address chronic issues like toxin buildup amid growing consumer demand for evidence-based wellness post-pandemic.[1] Timing aligns with advances in genetic engineering tools enabling enzyme activation, fueled by market forces like rising probiotic sales (projected multi-billion growth) and investor interest in sustainable agri-food tech via backers like Astanor.[1] It influences the ecosystem by pioneering narrower, mechanism-driven probiotics, potentially shifting standards from broad-spectrum to functional strains and bridging biotech with consumer health.
Next steps likely include scaling production, clinical validation via NIH/NSF grants, and market entry through SOSV networks, expanding to new toxin targets or partnerships in wellness.[1] Trends like AI-driven microbiome mapping and regulatory tailwinds for precision ferments will accelerate growth, evolving its influence toward mainstream adoption in detox and gut health. This biotech innovator, born from market gaps in Wyoming, exemplifies how targeted science unlocks broader human health potential.
Unlocked Labs has raised $600K across 2 funding rounds. Most recently, it raised $100K Seed in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2024 | $100K Seed | KRM Interests LLC, Oak HC/FT, Oyster Ventures, Pareto Holdings, Seaside Ventures, Social Capital | |
| Nov 1, 2022 | $500K Seed | Astanor Ventures, Seaside Ventures, SOSV, Mayfield, True Ventures |